Platinum-based Drugs Market By Type (Cisplatin, Oxaliplatin, Carboplatin, and Other), By Application (Colorectal Cancer, Ovarian Cancer, Lung Cancer, and Other), and By Region, Trends, Analysis and Forecast till 2030

Report Code: PMI430820 | Publish Date: May 2023 | No. of Pages: 144

Global Platinum Based Drugs Market Companies

  • Ask-Pharma
  • Mylan N.V.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Accord Healthcare
  • Guizhou YiBai Pharmaceutical Co., Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Qilu Pharmaceutical Co., Ltd.

Recent News:

  • According to PubMed Central article, the platinum-based medications oxaliplatin, carboplatin, and cisplatin are frequently used to eradicate cancer through chemotherapy. However, the therapeutic utility of platinum medicines is severely restricted by their adverse effects, which include significant systemic toxicity, lack of selectivity, and drug resistance. Pt-based anti-cancer medications have advanced significantly in cancer therapy in recent years thanks to developments in chemical synthesis and nanotechnology. Numerous tactics utilised the cisplatin-like anti-cancer mechanism and had some degree of success by altering already-approved platinum medicines.